2017
DOI: 10.1371/journal.pone.0187482
|View full text |Cite
|
Sign up to set email alerts
|

Engineering substrate promiscuity in halophilic alcohol dehydrogenase (HvADH2) by in silico design

Abstract: An alcohol dehydrogenase from the halophilic archaeon Haloferax volcanii (HvADH2) has been engineered by rational design to broaden its substrate scope towards the conversion of a range of aromatic substrates, including flurbiprofenol, that is an intermediate of the non-steroidal anti-inflammatory drug, flurbiprofen. Wild-type HvADH2 showed minimal activity with flurbiprofenol (11.1 mU/mg). A homology model of HvADH2 was built and docking experiments with this substrate revealed that the biphenyl rings of flur… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
12
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
4
1

Relationship

2
3

Authors

Journals

citations
Cited by 11 publications
(13 citation statements)
references
References 24 publications
1
12
0
Order By: Relevance
“…Immobilization within epoxy resin and metal organic framework material further improves the enzyme activity over a broader pH range and temperature and enhances enzyme stability in organic solvents (Alsafadi and Paradisi 2014;Carucci et al 2018). It is also possible to improve the substrate scope of HvADH2 for biocatalysis through rational in silico enzyme design (Cassidy et al 2017). H. volcanii expression systems can be used to overexpress and characterize industrially attractive enzymes from other halophiles (e.g.…”
Section: Biotechnological Potential Of H Volcaniimentioning
confidence: 99%
“…Immobilization within epoxy resin and metal organic framework material further improves the enzyme activity over a broader pH range and temperature and enhances enzyme stability in organic solvents (Alsafadi and Paradisi 2014;Carucci et al 2018). It is also possible to improve the substrate scope of HvADH2 for biocatalysis through rational in silico enzyme design (Cassidy et al 2017). H. volcanii expression systems can be used to overexpress and characterize industrially attractive enzymes from other halophiles (e.g.…”
Section: Biotechnological Potential Of H Volcaniimentioning
confidence: 99%
“…While HvADH1 had some interesting activity, HvADH2 had significantly better stability, unprecedented solvent tolerance, and broader substrate scope (Timpson et al 2013). HvADH2 soon became the benchmark for halophilic alcohol dehydrogenases with extensive further investigation into further enhancing its stability by covalent immobilization (Alsafadi and Paradisi 2014), mutagenesis to probe the active site and increase activity towards non-steroidal anti-inflammatory intermediates (Cassidy 2017) as well as its effective application in the asymmetric reduction of prochiral aromatic ketones (Alsafadi 2017). Two putative ADHs were then selected from the Red Sea and expressed in Haloferax volcanii using a stirred-tank bioreactor.…”
Section: Hmadh12 (Haloarcula Marismortui) Was Heterologously Overexpressed and Purified Frommentioning
confidence: 99%
“…This strain features a double deletion of endogenous adh1 and adh2 and is our strain of choice for expression of ADHs. Expression of HwADH followed established protocols previously reported for HvADH2 (Cassidy 2017). It is worth mentioning that Hqrw_1156adh was also cloned into pRSETb to probe expression in E.coli.…”
Section: Expression and Purification Of Hwadhmentioning
confidence: 99%
“…Recently, an ADH from the halophilic archaeon Haloferax volcanii (HvADH2) has been identified [6] and engineered by rational design to broaden its substrate scope towards the conversion of a variety of aromatic substrates. [7] Furthermore, a bacterial β-ketoacyl-ACP reductase (FabG) from Bacillus sp. ECU0013 [8] and NADPH-dependent (S)-carbonyl reductase from C. parapsilosis ATCC 7330 [9] reduce ethyl 2-oxo-4-phenylbutanoate (EOPB) to (S)-ethyl 2-hydroxy-4-phenylbutanoate (S-EHPB).…”
Section: Introductionmentioning
confidence: 99%
“…strain, Candida parapsilosis aldehyde dehydrogenase 5 (cpADH5), and ADH from Lactobacillus kefir , which are capable of reducing ketones with bulky side chains. Recently, an ADH from the halophilic archaeon Haloferax volcanii (HvADH2) has been identified and engineered by rational design to broaden its substrate scope towards the conversion of a variety of aromatic substrates . Furthermore, a bacterial β‐ketoacyl‐ACP reductase (FabG) from Bacillus sp.…”
Section: Introductionmentioning
confidence: 99%